Abstract
Bacitracin is an antimicrobial peptide that is frequently used as an active ingredient in antimicrobial ointments. However, bacitracin resistance is highly prevalent in community-associated MRSA (CA-MRSA) strains and significantly compromises the effectiveness of existing antimicrobial ointments. In this study, we aimed to develop novel adjuvants to enhance the antimicrobial activity of bacitracin by using alkyl gallates. The growth of MRSA USA300, the predominant CA-MRSA strain in the USA, was determined in the presence of bacitracin and alkyl gallates at various concentrations. The viability of USA300 and MDR clinical isolates of MRSA was measured after exposure to various combinations of bacitracin and alkyl gallates. Whereas 100 U/mL bacitracin did not inhibit USA300, 1 U/mL bacitracin in combination with as low as 2 mg/L octyl gallate (OG) and 8 mg/L dodecyl gallate (DG), respectively, completely inhibited the growth of USA300. Among the tested alkyl gallates, OG most significantly enhanced the bactericidal activity of bacitracin. For example, 10(-3) U/mL bacitracin with 5 mg/L OG effectively killed USA300, which is an ∼200 000-fold decrease in the MBC of bacitracin for USA300. Furthermore, bacitracin/OG combinations demon...Continue Reading
References
Dec 1, 1971·Proceedings of the National Academy of Sciences of the United States of America·K J Stone, J L Strominger
Mar 1, 1993·Antimicrobial Agents and Chemotherapy·K H RandD Bennett
Mar 10, 1998·Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]·B BellmanW R Bebell
Jun 30, 2000·Chemistry & Biology·G D Wright
Jan 5, 2002·Bioorganic & Medicinal Chemistry Letters·Isao KuboKen'ichi Fujita
Jan 28, 2005·Antimicrobial Agents and Chemotherapy·Hirofumi ShibataTomihiko Higuti
Apr 28, 2005·The Lancet Infectious Diseases·Nicola ZetolaWilliam R Bishai
Sep 5, 2006·Lancet·Ian M Gould
Oct 19, 2006·International Journal of Antimicrobial Agents·I M Gould
Nov 28, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Helen W BoucherJohn Bartlett
Jan 20, 2009·Biochimica Et Biophysica Acta·Jean-Marie Pagès, Leonard Amaral
Feb 19, 2009·Antimicrobial Agents and Chemotherapy·Hirofumi ShibataTomihiko Higuti
Oct 18, 2011·Emerging Infectious Diseases·Masahiro SuzukiYoshitsugu Iinuma
Feb 14, 2014·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Daniel J DiekemaGary V Doern
Apr 23, 2014·Proceedings of the National Academy of Sciences of the United States of America·Anne-Catrin UhlemannFranklin D Lowy